advertisement
Abstract #14914 Published in IGR 8-4
Ocular hypertension in children treated with brimonidine 0.2%. A clinical study
Montero de Espinosa I; Marquez de Aracena R; Morales CArchivos de la Sociedad Española de Oftalmologia 2006; 81: 155-159
PURPOSE: To evaluate the safety and efficacy of topical brimonidine 0.2% use in children. MATERIALS AND METHODS: A descriptive study of twelve successive children (21 eyes) who needed topical treatment of intraocular hypertension, and where the use of beta-blockers was contraindicated. RESULTS: During treatment we observed an average decrease of IOP of 5 SD 1.8 mmHg (21% of basal IOP), but found more common local symptoms, with stinging being complained of in 52.4% of cases. Somnolence was also complained of in two cases. LA: Spanish
Dr. I. Montero de Espinosa, Servicio de Oftalmologia, Hospital Universitario Virgen del Rocio, Sevilla, Spain. eignacio.montero.sspa@juntadeandalucia.es
Classification:
9.1.2 Juvenile glaucoma (Part of: 9 Clinical forms of glaucomas > 9.1 Developmental glaucomas)
11.3.3 Apraclonidine, brimonidine (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)
